HEADER TRANSFERASE 18-OCT-16 5M4C TITLE COMPLEX STRUCTURE OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT WITH A TITLE 2 THIENO[2,3-D]PYRIMIDIN INHIBITOR CRYSTALLIZED UNDER LOW-SALT TITLE 3 CONDITIONS COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASEIN KINASE II SUBUNIT ALPHA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CK II ALPHA; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CSNK2A1, CK2A1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PROTEIN KINASE CK2, CASEIN KINASE 2, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR K.NIEFIND,N.BISCHOFF,S.M.YARMOLUK,V.G.BDZHOLA,A.G.GOLUB,A.O.BALANDA, AUTHOR 2 A.O.PRYKHOD'KO REVDAT 6 17-JAN-24 5M4C 1 REMARK REVDAT 5 06-SEP-17 5M4C 1 REMARK REVDAT 4 17-MAY-17 5M4C 1 JRNL REVDAT 3 10-MAY-17 5M4C 1 JRNL REVDAT 2 25-JAN-17 5M4C 1 JRNL REVDAT 1 18-JAN-17 5M4C 0 JRNL AUTH K.NIEFIND,N.BISCHOFF,A.G.GOLUB,V.G.BDZHOLA,A.O.BALANDA, JRNL AUTH 2 A.O.PRYKHOD'KO,S.M.YARMOLUK JRNL TITL STRUCTURAL HYPERVARIABILITY OF THE TWO HUMAN PROTEIN KINASE JRNL TITL 2 CK2 CATALYTIC SUBUNIT PARALOGS REVEALED BY COMPLEX JRNL TITL 3 STRUCTURES WITH A FLAVONOL- AND A JRNL TITL 4 THIENO[2,3-D]PYRIMIDINE-BASED INHIBITOR. JRNL REF PHARMACEUTICALS V. 10 2017 JRNL REFN ESSN 1424-8247 JRNL PMID 28085026 JRNL DOI 10.3390/PH10010009 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH B.GUERRA,N.BISCHOFF,V.G.BDZHOLA,S.M.YARMOLUK,O.G.ISSINGER, REMARK 1 AUTH 2 A.G.GOLUB,K.NIEFIND REMARK 1 TITL A NOTE OF CAUTION ON THE ROLE OF HALOGEN BONDS FOR PROTEIN REMARK 1 TITL 2 KINASE/INHIBITOR RECOGNITION SUGGESTED BY HIGH- AND LOW-SALT REMARK 1 TITL 3 CK2ALPHA COMPLEX STRUCTURES. REMARK 1 REF ACS CHEM. BIOL. V. 10 1654 2015 REMARK 1 REFN ESSN 1554-8937 REMARK 1 PMID 25961323 REMARK 1 DOI 10.1021/ACSCHEMBIO.5B00235 REMARK 1 REFERENCE 2 REMARK 1 AUTH A.G.GOLUB,V.G.BDZHOLA,N.V.BRIUKHOVETSKA,A.O.BALANDA, REMARK 1 AUTH 2 O.P.KUKHARENKO,I.M.KOTEY,O.V.OSTRYNSKA,S.M.YARMOLUK REMARK 1 TITL SYNTHESIS AND BIOLOGICAL EVALUATION OF SUBSTITUTED REMARK 1 TITL 2 (THIENO[2,3-D]PYRIMIDIN-4-YLTHIO)CARBOXYLIC ACIDS AS REMARK 1 TITL 3 INHIBITORS OF HUMAN PROTEIN KINASE CK2. REMARK 1 REF EUR J MED CHEM V. 46 870 2011 REMARK 1 REFN ISSN 1768-3254 REMARK 1 PMID 21276643 REMARK 1 DOI 10.1016/J.EJMECH.2010.12.025 REMARK 1 REFERENCE 3 REMARK 1 AUTH A.G.GOLUB,V.G.BDZHOLA,Y.V.KYSHENIA,V.M.SAPELKIN, REMARK 1 AUTH 2 A.O.PRYKHOD'KO,O.P.KUKHARENKO,O.V.OSTRYNSKA,S.M.YARMOLUK REMARK 1 TITL STRUCTURE-BASED DISCOVERY OF NOVEL FLAVONOL INHIBITORS OF REMARK 1 TITL 2 HUMAN PROTEIN KINASE CK2. REMARK 1 REF MOL. CELL. BIOCHEM. V. 356 107 2011 REMARK 1 REFN ISSN 1573-4919 REMARK 1 PMID 21735097 REMARK 1 DOI 10.1007/S11010-011-0945-8 REMARK 2 REMARK 2 RESOLUTION. 1.94 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.10.1_2155: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.94 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.54 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.2 REMARK 3 NUMBER OF REFLECTIONS : 23281 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.158 REMARK 3 R VALUE (WORKING SET) : 0.157 REMARK 3 FREE R VALUE : 0.197 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.740 REMARK 3 FREE R VALUE TEST SET COUNT : 1104 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 41.5450 - 3.8693 1.00 3030 167 0.1482 0.1720 REMARK 3 2 3.8693 - 3.0715 1.00 2915 140 0.1360 0.1736 REMARK 3 3 3.0715 - 2.6833 1.00 2880 149 0.1596 0.2013 REMARK 3 4 2.6833 - 2.4380 1.00 2864 128 0.1613 0.2235 REMARK 3 5 2.4380 - 2.2633 1.00 2847 141 0.1643 0.2149 REMARK 3 6 2.2633 - 2.1298 1.00 2848 139 0.1731 0.2428 REMARK 3 7 2.1298 - 2.0232 1.00 2836 143 0.1813 0.2104 REMARK 3 8 2.0232 - 1.9351 0.70 1957 97 0.2066 0.2701 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.170 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 18.890 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.84 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 2919 REMARK 3 ANGLE : 1.031 3950 REMARK 3 CHIRALITY : 0.059 406 REMARK 3 PLANARITY : 0.006 507 REMARK 3 DIHEDRAL : 16.276 1750 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 9 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 3 THROUGH 24 ) REMARK 3 ORIGIN FOR THE GROUP (A): 4.4431 12.8448 -24.8878 REMARK 3 T TENSOR REMARK 3 T11: 0.2891 T22: 0.2212 REMARK 3 T33: 0.1991 T12: -0.0266 REMARK 3 T13: 0.0404 T23: 0.0524 REMARK 3 L TENSOR REMARK 3 L11: 3.5856 L22: 5.5211 REMARK 3 L33: 0.9107 L12: -0.1300 REMARK 3 L13: 0.1391 L23: 1.2567 REMARK 3 S TENSOR REMARK 3 S11: 0.0271 S12: 0.6027 S13: 0.2142 REMARK 3 S21: -0.4075 S22: 0.1472 S23: 0.2778 REMARK 3 S31: -0.3491 S32: 0.0719 S33: -0.0243 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 25 THROUGH 44 ) REMARK 3 ORIGIN FOR THE GROUP (A): -20.5072 -0.5973 -23.1657 REMARK 3 T TENSOR REMARK 3 T11: 0.2987 T22: 0.2395 REMARK 3 T33: 0.2508 T12: 0.0361 REMARK 3 T13: 0.0323 T23: 0.0171 REMARK 3 L TENSOR REMARK 3 L11: 2.0203 L22: 3.5759 REMARK 3 L33: 2.1265 L12: 0.9172 REMARK 3 L13: -0.1122 L23: -0.0905 REMARK 3 S TENSOR REMARK 3 S11: -0.0271 S12: 0.4185 S13: 0.2054 REMARK 3 S21: -0.5153 S22: 0.1246 S23: -0.2730 REMARK 3 S31: -0.4130 S32: -0.3014 S33: -0.0227 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 45 THROUGH 74 ) REMARK 3 ORIGIN FOR THE GROUP (A): -20.4376 -4.1763 -14.0103 REMARK 3 T TENSOR REMARK 3 T11: 0.1853 T22: 0.1717 REMARK 3 T33: 0.2123 T12: 0.0017 REMARK 3 T13: 0.0052 T23: -0.0375 REMARK 3 L TENSOR REMARK 3 L11: 3.3474 L22: 4.7048 REMARK 3 L33: 3.2808 L12: 0.9184 REMARK 3 L13: 0.6293 L23: -0.7607 REMARK 3 S TENSOR REMARK 3 S11: 0.1740 S12: -0.2900 S13: 0.3156 REMARK 3 S21: 0.0520 S22: -0.0858 S23: -0.0741 REMARK 3 S31: -0.3743 S32: -0.1680 S33: -0.0632 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 75 THROUGH 108 ) REMARK 3 ORIGIN FOR THE GROUP (A): -14.5906 1.9412 -22.4149 REMARK 3 T TENSOR REMARK 3 T11: 0.2289 T22: 0.2407 REMARK 3 T33: 0.2153 T12: 0.0455 REMARK 3 T13: -0.0462 T23: 0.0089 REMARK 3 L TENSOR REMARK 3 L11: 2.9901 L22: 1.4168 REMARK 3 L33: 1.4317 L12: 1.4842 REMARK 3 L13: -0.2253 L23: 0.1080 REMARK 3 S TENSOR REMARK 3 S11: -0.0644 S12: 0.2954 S13: 0.4689 REMARK 3 S21: -0.1603 S22: -0.0061 S23: 0.3204 REMARK 3 S31: -0.3335 S32: -0.4194 S33: 0.0505 REMARK 3 TLS GROUP : 5 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 109 THROUGH 168 ) REMARK 3 ORIGIN FOR THE GROUP (A): -2.0268 -6.6087 -10.5116 REMARK 3 T TENSOR REMARK 3 T11: 0.1610 T22: 0.1015 REMARK 3 T33: 0.0990 T12: -0.0080 REMARK 3 T13: -0.0050 T23: -0.0168 REMARK 3 L TENSOR REMARK 3 L11: 2.0143 L22: 2.0003 REMARK 3 L33: 1.0320 L12: 0.0512 REMARK 3 L13: 0.4213 L23: -0.1416 REMARK 3 S TENSOR REMARK 3 S11: 0.0380 S12: -0.1962 S13: -0.1844 REMARK 3 S21: 0.1534 S22: -0.0196 S23: -0.0244 REMARK 3 S31: 0.0861 S32: -0.0478 S33: -0.0258 REMARK 3 TLS GROUP : 6 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 169 THROUGH 227 ) REMARK 3 ORIGIN FOR THE GROUP (A): 0.8440 7.3946 -9.6131 REMARK 3 T TENSOR REMARK 3 T11: 0.1270 T22: 0.0882 REMARK 3 T33: 0.1099 T12: 0.0070 REMARK 3 T13: 0.0138 T23: -0.0356 REMARK 3 L TENSOR REMARK 3 L11: 1.4786 L22: 0.6765 REMARK 3 L33: 1.7553 L12: 0.4534 REMARK 3 L13: 0.0041 L23: 0.3390 REMARK 3 S TENSOR REMARK 3 S11: 0.0555 S12: -0.0513 S13: 0.1348 REMARK 3 S21: -0.0144 S22: 0.0057 S23: 0.0808 REMARK 3 S31: -0.1494 S32: -0.0292 S33: -0.0208 REMARK 3 TLS GROUP : 7 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 228 THROUGH 280 ) REMARK 3 ORIGIN FOR THE GROUP (A): 8.1212 14.1355 3.9917 REMARK 3 T TENSOR REMARK 3 T11: 0.2019 T22: 0.2136 REMARK 3 T33: 0.1757 T12: -0.0261 REMARK 3 T13: 0.0051 T23: -0.0812 REMARK 3 L TENSOR REMARK 3 L11: 2.5464 L22: 3.6298 REMARK 3 L33: 3.2396 L12: 0.9077 REMARK 3 L13: -0.0967 L23: 0.0005 REMARK 3 S TENSOR REMARK 3 S11: 0.0023 S12: -0.2495 S13: 0.2282 REMARK 3 S21: 0.3130 S22: 0.1028 S23: -0.2354 REMARK 3 S31: -0.3079 S32: 0.0937 S33: -0.0416 REMARK 3 TLS GROUP : 8 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 281 THROUGH 314 ) REMARK 3 ORIGIN FOR THE GROUP (A): 13.3764 -0.7802 -0.4765 REMARK 3 T TENSOR REMARK 3 T11: 0.2170 T22: 0.2518 REMARK 3 T33: 0.1941 T12: -0.0046 REMARK 3 T13: -0.0344 T23: -0.0089 REMARK 3 L TENSOR REMARK 3 L11: 1.8199 L22: 3.7969 REMARK 3 L33: 1.1798 L12: -0.1553 REMARK 3 L13: 0.5438 L23: 0.2497 REMARK 3 S TENSOR REMARK 3 S11: 0.0605 S12: -0.2890 S13: -0.1571 REMARK 3 S21: 0.5468 S22: -0.0017 S23: -0.3075 REMARK 3 S31: 0.0560 S32: 0.1944 S33: -0.0437 REMARK 3 TLS GROUP : 9 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 315 THROUGH 331 ) REMARK 3 ORIGIN FOR THE GROUP (A): 13.7893 -9.1664 -13.6827 REMARK 3 T TENSOR REMARK 3 T11: 0.1499 T22: 0.2026 REMARK 3 T33: 0.1834 T12: 0.0154 REMARK 3 T13: -0.0012 T23: -0.0501 REMARK 3 L TENSOR REMARK 3 L11: 4.6518 L22: 1.8027 REMARK 3 L33: 6.5024 L12: -0.5681 REMARK 3 L13: 0.0334 L23: -1.6089 REMARK 3 S TENSOR REMARK 3 S11: 0.0265 S12: 0.5059 S13: -0.3495 REMARK 3 S21: -0.1972 S22: -0.0947 S23: -0.1995 REMARK 3 S31: 0.3355 S32: 0.2761 S33: 0.0194 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5M4C COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 18-OCT-16. REMARK 100 THE DEPOSITION ID IS D_1200001903. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-OCT-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06DA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23281 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.935 REMARK 200 RESOLUTION RANGE LOW (A) : 41.600 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.0 REMARK 200 DATA REDUNDANCY : 6.300 REMARK 200 R MERGE (I) : 0.09820 REMARK 200 R SYM (I) : 0.09820 REMARK 200 FOR THE DATA SET : 15.2500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.94 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 62.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.20 REMARK 200 R MERGE FOR SHELL (I) : 0.73050 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.260 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 2PVR REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.33 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.96 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN STOCK SOLUTION: 6 MG/M REMARK 280 CK2ALPHA1-335 IN 0.5 M NACL, 25 MM TRIS/HCL, PH 8.5; INHIBITOR REMARK 280 STOCK SOLUTION: 10 MM INHIBITOR IN DMSO; PROTEIN/INHIBITOR REMARK 280 COMPLEX SOLUTION: 90 MICROLITER PROTEIN STOCK SOLUTION + 10 REMARK 280 MICROLITER INHIBITOR STOCK SOLUTION; RESERVOIR SOLUTION: 24 % (W/ REMARK 280 V) PEG8000, 0.2 M KCL; DROP SOLUTION BEFORE EQULIBRATION: 0.3 REMARK 280 MICROLITER PROTEIN/INHIBITOR COMPLEX SOLUTION + 0.3 MICROLITER REMARK 280 RESERVOIR SOLUTION, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.05200 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 41.17050 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 39.70900 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 41.17050 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.05200 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 39.70900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 620 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15490 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -14.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 ALA A 332 REMARK 465 ARG A 333 REMARK 465 MET A 334 REMARK 465 GLY A 335 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 688 O HOH A 717 2.13 REMARK 500 O HOH A 691 O HOH A 696 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 72 86.63 -48.93 REMARK 500 ASP A 156 42.55 -148.38 REMARK 500 ASP A 175 76.20 51.53 REMARK 500 ALA A 193 171.88 60.24 REMARK 500 MET A 208 54.00 -93.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 728 DISTANCE = 6.97 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 7EY A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 404 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5M44 RELATED DB: PDB DBREF 5M4C A 1 335 UNP P68400 CSK21_HUMAN 1 335 SEQRES 1 A 335 MET SER GLY PRO VAL PRO SER ARG ALA ARG VAL TYR THR SEQRES 2 A 335 ASP VAL ASN THR HIS ARG PRO ARG GLU TYR TRP ASP TYR SEQRES 3 A 335 GLU SER HIS VAL VAL GLU TRP GLY ASN GLN ASP ASP TYR SEQRES 4 A 335 GLN LEU VAL ARG LYS LEU GLY ARG GLY LYS TYR SER GLU SEQRES 5 A 335 VAL PHE GLU ALA ILE ASN ILE THR ASN ASN GLU LYS VAL SEQRES 6 A 335 VAL VAL LYS ILE LEU LYS PRO VAL LYS LYS LYS LYS ILE SEQRES 7 A 335 LYS ARG GLU ILE LYS ILE LEU GLU ASN LEU ARG GLY GLY SEQRES 8 A 335 PRO ASN ILE ILE THR LEU ALA ASP ILE VAL LYS ASP PRO SEQRES 9 A 335 VAL SER ARG THR PRO ALA LEU VAL PHE GLU HIS VAL ASN SEQRES 10 A 335 ASN THR ASP PHE LYS GLN LEU TYR GLN THR LEU THR ASP SEQRES 11 A 335 TYR ASP ILE ARG PHE TYR MET TYR GLU ILE LEU LYS ALA SEQRES 12 A 335 LEU ASP TYR CYS HIS SER MET GLY ILE MET HIS ARG ASP SEQRES 13 A 335 VAL LYS PRO HIS ASN VAL MET ILE ASP HIS GLU HIS ARG SEQRES 14 A 335 LYS LEU ARG LEU ILE ASP TRP GLY LEU ALA GLU PHE TYR SEQRES 15 A 335 HIS PRO GLY GLN GLU TYR ASN VAL ARG VAL ALA SER ARG SEQRES 16 A 335 TYR PHE LYS GLY PRO GLU LEU LEU VAL ASP TYR GLN MET SEQRES 17 A 335 TYR ASP TYR SER LEU ASP MET TRP SER LEU GLY CYS MET SEQRES 18 A 335 LEU ALA SER MET ILE PHE ARG LYS GLU PRO PHE PHE HIS SEQRES 19 A 335 GLY HIS ASP ASN TYR ASP GLN LEU VAL ARG ILE ALA LYS SEQRES 20 A 335 VAL LEU GLY THR GLU ASP LEU TYR ASP TYR ILE ASP LYS SEQRES 21 A 335 TYR ASN ILE GLU LEU ASP PRO ARG PHE ASN ASP ILE LEU SEQRES 22 A 335 GLY ARG HIS SER ARG LYS ARG TRP GLU ARG PHE VAL HIS SEQRES 23 A 335 SER GLU ASN GLN HIS LEU VAL SER PRO GLU ALA LEU ASP SEQRES 24 A 335 PHE LEU ASP LYS LEU LEU ARG TYR ASP HIS GLN SER ARG SEQRES 25 A 335 LEU THR ALA ARG GLU ALA MET GLU HIS PRO TYR PHE TYR SEQRES 26 A 335 THR VAL VAL LYS ASP GLN ALA ARG MET GLY HET 7EY A 401 22 HET CL A 402 1 HET GOL A 403 6 HET GOL A 404 6 HETNAM 7EY 3-[5-(4-METHYLPHENYL)THIENO[2,3-D]PYRIMIDIN-4- HETNAM 2 7EY YL]SULFANYLPROPANOIC ACID HETNAM CL CHLORIDE ION HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 7EY C16 H14 N2 O2 S2 FORMUL 3 CL CL 1- FORMUL 4 GOL 2(C3 H8 O3) FORMUL 6 HOH *228(H2 O) HELIX 1 AA1 ASP A 14 ARG A 19 1 6 HELIX 2 AA2 PRO A 20 ASP A 25 1 6 HELIX 3 AA3 TYR A 26 HIS A 29 5 4 HELIX 4 AA4 ASN A 35 ASP A 37 5 3 HELIX 5 AA5 LYS A 74 ARG A 89 1 16 HELIX 6 AA6 ASP A 120 TYR A 125 1 6 HELIX 7 AA7 GLN A 126 LEU A 128 5 3 HELIX 8 AA8 THR A 129 MET A 150 1 22 HELIX 9 AA9 LYS A 158 HIS A 160 5 3 HELIX 10 AB1 HIS A 166 ARG A 169 5 4 HELIX 11 AB2 ASP A 175 ALA A 179 5 5 HELIX 12 AB3 SER A 194 LYS A 198 5 5 HELIX 13 AB4 GLY A 199 VAL A 204 1 6 HELIX 14 AB5 TYR A 211 ARG A 228 1 18 HELIX 15 AB6 ASP A 237 GLY A 250 1 14 HELIX 16 AB7 GLY A 250 ASN A 262 1 13 HELIX 17 AB8 ASP A 266 GLY A 274 1 9 HELIX 18 AB9 ARG A 280 VAL A 285 5 6 HELIX 19 AC1 ASN A 289 VAL A 293 5 5 HELIX 20 AC2 SER A 294 LEU A 305 1 12 HELIX 21 AC3 ASP A 308 ARG A 312 5 5 HELIX 22 AC4 THR A 314 GLU A 320 1 7 HELIX 23 AC5 HIS A 321 TYR A 323 5 3 HELIX 24 AC6 PHE A 324 GLN A 331 1 8 SHEET 1 AA1 5 TYR A 39 ARG A 47 0 SHEET 2 AA1 5 SER A 51 ASN A 58 -1 O VAL A 53 N LEU A 45 SHEET 3 AA1 5 LYS A 64 LEU A 70 -1 O VAL A 67 N PHE A 54 SHEET 4 AA1 5 PRO A 109 GLU A 114 -1 O PHE A 113 N VAL A 66 SHEET 5 AA1 5 LEU A 97 LYS A 102 -1 N ASP A 99 O VAL A 112 SHEET 1 AA2 2 ILE A 152 MET A 153 0 SHEET 2 AA2 2 GLU A 180 PHE A 181 -1 O GLU A 180 N MET A 153 SHEET 1 AA3 2 VAL A 162 ASP A 165 0 SHEET 2 AA3 2 LYS A 170 LEU A 173 -1 O LYS A 170 N ASP A 165 CISPEP 1 GLU A 230 PRO A 231 0 -5.65 SITE 1 AC1 12 LEU A 45 VAL A 53 VAL A 66 LYS A 68 SITE 2 AC1 12 PHE A 113 GLU A 114 VAL A 116 MET A 163 SITE 3 AC1 12 ILE A 174 ASP A 175 HOH A 522 HOH A 552 SITE 1 AC2 5 HIS A 148 THR A 314 ALA A 315 HOH A 598 SITE 2 AC2 5 HOH A 710 SITE 1 AC3 7 PHE A 54 ILE A 69 LYS A 303 GLU A 317 SITE 2 AC3 7 GLU A 320 HIS A 321 HOH A 599 SITE 1 AC4 6 GLN A 36 TYR A 39 ALA A 110 GLU A 320 SITE 2 AC4 6 HOH A 534 HOH A 564 CRYST1 48.104 79.418 82.341 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020788 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012592 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012145 0.00000